Haleos Labs Limited (NSE:HALEOSLABS)
India · Delayed Price · Currency is INR 1,287.70
+33.90 (2.70%)
Apr 2, 2026, 3:29 PM IST
Haleos Labs Market Cap
Haleos Labs has a market cap or net worth of 3.89 billion as of April 2, 2026. Its market cap has increased by 18.61% in one year.
Market Cap
3.89B
Enterprise Value
4.74B
Revenue
3.48B
Ranking
n/a
PE Ratio
19.61
Stock Price
1,287.70
Market Cap Chart
Since August 17, 2017, Haleos Labs's market cap has increased from 407.69M to 3.89B, an increase of 854.91%. That is a compound annual growth rate of 29.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 3.89B | -2.74% |
| Dec 31, 2025 | 4.00B | 12.59% |
| Dec 31, 2024 | 3.56B | 122.05% |
| Dec 29, 2023 | 1.60B | -15.33% |
| Dec 30, 2022 | 1.89B | -14.48% |
| Dec 31, 2021 | 2.21B | 11.54% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Aug 17, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biocon | 591.03B |
| Anthem Biosciences | 373.86B |
| OneSource Specialty Pharma | 164.64B |
| Concord Biotech | 106.71B |
| Blue Jet Healthcare | 60.89B |
| Supriya Lifescience | 49.27B |
| Zota Health Care | 37.51B |
| Dishman Carbogen Amcis | 22.91B |